logo-loader

Apollon Formularies' says new state-of-the art distiller increases production more than 50-fold

Published: 13:16 16 Sep 2021 BST

Apollon Formularies (AQSE:APOL)' (AQSE:APOL) Stene Jacobs, COO, joins Proactive London to explain the announcement of a substantial increase in its production capacity in Negril, Jamaica.

He details how this will create further revenue generation opportunities with its state-of-the art distiller increasing production more than 50-fold compared with current levels.

The company has installed a specialist sonicator, which allows for the production of nano-particle medicines as well as water-oil emulsions. In addition, it has bought an industrial freeze drier, allowing it more flexibility to store freeze dried biomass for use on demand as well as for pharmaceutical applications.

HANetf founder and co-CEO discusses shift to active management in ETF market

HANetf founder and co-CEO Hector McNeil tells Proactive's Stephen Gunnion about shifting trends in the exchange-traded fund (ETF) market in the United States, indicating a big move towards active management within ETFs. Despite the European market lagging behind the US by three to five years,...

12 hours, 52 minutes ago